Literature DB >> 36125669

Developing skin cancer education materials for darker skin populations: crowdsourced design, message targeting, and acral lentiginous melanoma.

Sean J Upshaw1, Jakob D Jensen2, Elizabeth A Giorgi2, Manusheela Pokharel3, Helen M Lillie4, Dallin R Adams2, Kevin K John5, Yelena P Wu6,7, Douglas Grossman6,7.   

Abstract

Despite decreased susceptibility, darker skin individuals who develop melanoma have worse survival. This disparity in melanoma mortality is the largest for any cancer, and partly driven by a lack of patient education materials targeted to darker skin populations in whom acral lentiginous melanoma (ALM) is the most common subtype. To address this communication disparity, the current study reports a multi-phase design process that leverages crowdsourcing and message testing to develop ALM-focused patient education materials for darker skin populations. Crowdsourced design was utilized to develop a pool of designs (phase 1), the pool was narrowed and thematically analyzed (phase 2), and select designs were evaluated via a message experiment (N = 1877). For darker skin populations, designs that depicted people enhanced knowledge of ALM through message memorability. The current study engages melanoma disparities by providing ALM patient education materials for darker skin populations vetted via a multi-phase process.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acral lentiginous melanoma; Crowdsourced design; Darker skin populations; Disparity; Targeted communication

Year:  2022        PMID: 36125669     DOI: 10.1007/s10865-022-00362-x

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  33 in total

1.  Theorizing the Impact of Targeted Narratives: Model Admiration and Narrative Memorability.

Authors:  Katheryn R Christy; Jakob D Jensen; Susan H Sarapin; Robert N Yale; Jeremy Weaver; Manusheela Pokharel
Journal:  J Health Commun       Date:  2017-04-17

Review 2.  Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians.

Authors:  Katina Byrd-Miles; Ella L Toombs; Gary L Peck
Journal:  J Drugs Dermatol       Date:  2007-01       Impact factor: 2.114

3.  A survey of self-reported skin disease in the elderly African-American population.

Authors:  Katherine L Caretti; Darius R Mehregan; David A Mehregan
Journal:  Int J Dermatol       Date:  2014-11-27       Impact factor: 2.736

4.  Melanoma Perception in People of Color: A Targeted Educational Intervention.

Authors:  Lucy X Chao; Stavonnie S L Patterson; Alfred W Rademaker; Dachao Liu; Roopal V Kundu
Journal:  Am J Clin Dermatol       Date:  2017-06       Impact factor: 7.403

5.  Accuracy of self-report in assessing Fitzpatrick skin phototypes I through VI.

Authors:  Steven Eilers; Daniel Q Bach; Rikki Gaber; Hanz Blatt; Yanina Guevara; Katie Nitsche; Roopal V Kundu; June K Robinson
Journal:  JAMA Dermatol       Date:  2013-11       Impact factor: 10.282

Review 6.  Skin cancer in skin of color.

Authors:  Porcia T Bradford
Journal:  Dermatol Nurs       Date:  2009 Jul-Aug

7.  Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.

Authors:  Porcia T Bradford; Alisa M Goldstein; Mary L McMaster; Margaret A Tucker
Journal:  Arch Dermatol       Date:  2009-04

8.  Adapting a Skin Cancer Prevention Intervention for Multiethnic Adolescents.

Authors:  Kevin D Cassel; Drph Anh Tran; Lynn Murakami-Akatsuka; Jodi Tanabe-Hanzawa; Terrilea Burnett; Christopher Lum
Journal:  Am J Health Behav       Date:  2018-03-01

9.  Acral Lentiginous Melanoma: A Rare Variant With Unique Diagnostic Challenges.

Authors:  Brett C Brazen; Taylor Gray; Maheera Farsi; Richard Miller
Journal:  Cureus       Date:  2020-06-03

10.  Mapping of Crowdsourcing in Health: Systematic Review.

Authors:  Perrine Créquit; Ghizlène Mansouri; Mehdi Benchoufi; Alexandre Vivot; Philippe Ravaud
Journal:  J Med Internet Res       Date:  2018-05-15       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.